Individual Detail
Ray, UCLA A
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Nein |
1.0 |
8 |
2 |
20 |
3.50 |
0.00 |
70 |
Stanford Chicago |
1.0 |
5 |
3 |
20 |
1.75 |
0.00 |
35 |
UCLA C |
1.0 |
10 |
2 |
20 |
4.50 |
0.00 |
90 |
UCI |
1.0 |
6 |
2 |
23 |
2.17 |
0.00 |
50 |
Stanford B12 |
1.0 |
5 |
0 |
20 |
2.50 |
0.00 |
50 |
UCLA D |
1.0 |
7 |
2 |
20 |
3.00 |
0.00 |
60 |
UCLA B |
1.0 |
6 |
1 |
20 |
2.75 |
0.00 |
55 |
Berkeley |
1.0 |
6 |
1 |
20 |
2.75 |
0.00 |
55 |
Riboflavin |
1.0 |
6 |
3 |
20 |
2.25 |
0.00 |
45 |
| Total |
9.0 |
59 |
16 |
183 |
2.79 |
0.00 |
510 |
Kha, UCLA A
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Nein |
1.0 |
2 |
2 |
20 |
0.50 |
0.00 |
10 |
Stanford Chicago |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA C |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCI |
1.0 |
2 |
1 |
23 |
0.65 |
0.00 |
15 |
Stanford B12 |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA D |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA B |
1.0 |
2 |
2 |
20 |
0.50 |
0.00 |
10 |
Berkeley |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Riboflavin |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
| Total |
9.0 |
21 |
5 |
183 |
1.01 |
0.00 |
185 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Nein |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford Chicago |
1.0 |
0 |
2 |
20 |
-0.50 |
0.00 |
-10 |
UCLA C |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCI |
1.0 |
1 |
0 |
23 |
0.43 |
0.00 |
10 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA D |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA B |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Riboflavin |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
9.0 |
7 |
3 |
183 |
0.30 |
0.00 |
55 |
Jay, UCLA A
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Nein |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Stanford Chicago |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCLA C |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCI |
1.0 |
3 |
0 |
23 |
1.30 |
0.00 |
30 |
Stanford B12 |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA D |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA B |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Berkeley |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Riboflavin |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
| Total |
9.0 |
13 |
1 |
183 |
0.68 |
0.00 |
125 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA A |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCI |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
Stanford B12 |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
UCLA D |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA B |
1.0 |
0 |
2 |
20 |
-0.50 |
0.00 |
-10 |
Berkeley |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Riboflavin |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
Stanford Chicago |
1.0 |
3 |
2 |
20 |
1.00 |
0.00 |
20 |
UCLA C |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
| Total |
9.0 |
15 |
7 |
180 |
0.64 |
0.00 |
115 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA A |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCI |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
Stanford B12 |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA D |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Berkeley |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
Riboflavin |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Stanford Chicago |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA C |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
8.0 |
15 |
3 |
160 |
0.84 |
0.00 |
135 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA A |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCI |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford B12 |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
UCLA D |
1.0 |
5 |
2 |
20 |
2.00 |
0.00 |
40 |
UCLA B |
1.0 |
7 |
0 |
20 |
3.50 |
0.00 |
70 |
Riboflavin |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
Stanford Chicago |
1.0 |
5 |
0 |
20 |
2.50 |
0.00 |
50 |
UCLA C |
1.0 |
4 |
1 |
20 |
1.75 |
0.00 |
35 |
| Total |
8.0 |
31 |
5 |
160 |
1.78 |
0.00 |
285 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA A |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
Stanford B12 |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA B |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Riboflavin |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCLA C |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
| Total |
6.0 |
10 |
2 |
120 |
0.75 |
0.00 |
90 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCI |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA D |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
UCLA B |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Berkeley |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford Chicago |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
| Total |
5.0 |
6 |
0 |
100 |
0.60 |
0.00 |
60 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Riboflavin |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Nein |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford Chicago |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA C |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA A |
1.0 |
1 |
0 |
23 |
0.43 |
0.00 |
10 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA D |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCLA B |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
9.0 |
4 |
1 |
183 |
0.19 |
0.00 |
35 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Riboflavin |
1.0 |
10 |
2 |
20 |
4.50 |
0.00 |
90 |
Nein |
1.0 |
11 |
1 |
20 |
5.25 |
0.00 |
105 |
Stanford Chicago |
1.0 |
13 |
3 |
20 |
5.75 |
0.00 |
115 |
UCLA C |
1.0 |
13 |
0 |
20 |
6.50 |
0.00 |
130 |
UCLA A |
1.0 |
10 |
3 |
23 |
3.70 |
0.00 |
85 |
Stanford B12 |
1.0 |
6 |
1 |
20 |
2.75 |
0.00 |
55 |
UCLA D |
1.0 |
15 |
1 |
20 |
7.25 |
0.00 |
145 |
UCLA B |
1.0 |
17 |
1 |
20 |
8.25 |
0.00 |
165 |
Berkeley |
1.0 |
7 |
0 |
20 |
3.50 |
0.00 |
70 |
| Total |
9.0 |
102 |
12 |
183 |
5.25 |
0.00 |
960 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Riboflavin |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Nein |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford Chicago |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA C |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA A |
1.0 |
0 |
1 |
23 |
-0.22 |
0.00 |
-5 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA D |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA B |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
| Total |
9.0 |
3 |
1 |
183 |
0.14 |
0.00 |
25 |
Jason, Riboflavin
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCI |
1.0 |
4 |
2 |
20 |
1.50 |
0.00 |
30 |
Stanford B12 |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCLA D |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
UCLA B |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Berkeley |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Nein |
1.0 |
7 |
1 |
20 |
3.25 |
0.00 |
65 |
Stanford Chicago |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCLA C |
1.0 |
6 |
0 |
20 |
3.00 |
0.00 |
60 |
UCLA A |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
| Total |
9.0 |
32 |
5 |
180 |
1.64 |
0.00 |
295 |
Neel, Riboflavin
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCI |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
Stanford B12 |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA D |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
UCLA B |
1.0 |
4 |
2 |
20 |
1.50 |
0.00 |
30 |
Nein |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Stanford Chicago |
1.0 |
6 |
2 |
20 |
2.50 |
0.00 |
50 |
UCLA C |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCLA A |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
| Total |
8.0 |
25 |
7 |
160 |
1.34 |
0.00 |
215 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCI |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford B12 |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
| Total |
2.0 |
1 |
0 |
40 |
0.25 |
0.00 |
10 |
Phil, Riboflavin
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCI |
0.9 |
1 |
0 |
18 |
0.56 |
0.00 |
10 |
Stanford B12 |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
UCLA D |
1.0 |
5 |
2 |
20 |
2.00 |
0.00 |
40 |
UCLA B |
1.0 |
1 |
2 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
0 |
2 |
20 |
-0.50 |
0.00 |
-10 |
Nein |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford Chicago |
1.0 |
4 |
1 |
20 |
1.75 |
0.00 |
35 |
UCLA C |
1.0 |
2 |
3 |
20 |
0.25 |
0.00 |
5 |
UCLA A |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
| Total |
8.9 |
17 |
11 |
178 |
0.65 |
0.00 |
115 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Nein |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Stanford Chicago |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA C |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA A |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
| Total |
4.0 |
4 |
0 |
80 |
0.50 |
0.00 |
40 |
Craig, Stanford B12
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Berkeley |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
Riboflavin |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Nein |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Stanford Chicago |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA C |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA A |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCI |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCLA D |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA B |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
9.0 |
8 |
4 |
180 |
0.33 |
0.00 |
60 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Berkeley |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
Riboflavin |
1.0 |
6 |
1 |
20 |
2.75 |
0.00 |
55 |
Nein |
1.0 |
6 |
2 |
20 |
2.50 |
0.00 |
50 |
Stanford Chicago |
1.0 |
6 |
1 |
20 |
2.75 |
0.00 |
55 |
UCLA C |
1.0 |
6 |
0 |
20 |
3.00 |
0.00 |
60 |
UCLA A |
1.0 |
7 |
1 |
20 |
3.25 |
0.00 |
65 |
UCI |
1.0 |
6 |
0 |
20 |
3.00 |
0.00 |
60 |
UCLA D |
1.0 |
8 |
0 |
20 |
4.00 |
0.00 |
80 |
UCLA B |
1.0 |
4 |
1 |
20 |
1.75 |
0.00 |
35 |
| Total |
9.0 |
53 |
6 |
180 |
2.78 |
0.00 |
500 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Berkeley |
1.0 |
2 |
2 |
20 |
0.50 |
0.00 |
10 |
Riboflavin |
1.0 |
5 |
0 |
20 |
2.50 |
0.00 |
50 |
Nein |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Stanford Chicago |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA C |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA A |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCI |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA D |
1.0 |
6 |
1 |
20 |
2.75 |
0.00 |
55 |
UCLA B |
1.0 |
6 |
0 |
20 |
3.00 |
0.00 |
60 |
| Total |
9.0 |
29 |
4 |
180 |
1.50 |
0.00 |
270 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford Chicago |
1.0 |
7 |
0 |
20 |
3.50 |
0.00 |
70 |
UCLA C |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
UCLA A |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCI |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCLA D |
1.0 |
1 |
2 |
20 |
0.00 |
0.00 |
0 |
UCLA B |
1.0 |
2 |
2 |
20 |
0.50 |
0.00 |
10 |
| Total |
6.0 |
16 |
6 |
120 |
1.08 |
0.00 |
130 |
Paul, Berkeley
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford B12 |
1.0 |
4 |
1 |
20 |
1.75 |
0.00 |
35 |
UCLA D |
1.0 |
6 |
2 |
20 |
2.50 |
0.00 |
50 |
UCLA B |
1.0 |
9 |
2 |
20 |
4.00 |
0.00 |
80 |
Riboflavin |
1.0 |
6 |
2 |
20 |
2.50 |
0.00 |
50 |
Nein |
1.0 |
8 |
0 |
20 |
4.00 |
0.00 |
80 |
Stanford Chicago |
1.0 |
6 |
0 |
20 |
3.00 |
0.00 |
60 |
UCLA C |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
UCLA A |
1.0 |
6 |
2 |
20 |
2.50 |
0.00 |
50 |
UCI |
1.0 |
8 |
0 |
20 |
4.00 |
0.00 |
80 |
| Total |
9.0 |
57 |
9 |
180 |
2.92 |
0.00 |
525 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford B12 |
1.0 |
4 |
2 |
20 |
1.50 |
0.00 |
30 |
UCLA D |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCLA B |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Riboflavin |
1.0 |
6 |
1 |
20 |
2.75 |
0.00 |
55 |
Nein |
1.0 |
6 |
1 |
20 |
2.75 |
0.00 |
55 |
Stanford Chicago |
1.0 |
5 |
3 |
20 |
1.75 |
0.00 |
35 |
UCLA C |
1.0 |
10 |
2 |
20 |
4.50 |
0.00 |
90 |
UCLA A |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
UCI |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
| Total |
9.0 |
40 |
12 |
180 |
1.89 |
0.00 |
340 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford B12 |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA D |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
UCLA B |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Riboflavin |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Nein |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford Chicago |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA C |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCLA A |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCI |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
| Total |
9.0 |
10 |
3 |
180 |
0.47 |
0.00 |
85 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford B12 |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA D |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA B |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
Riboflavin |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Nein |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Stanford Chicago |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA C |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA A |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCI |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
| Total |
9.0 |
18 |
2 |
180 |
0.94 |
0.00 |
170 |
Elliot, Stanford Chicago
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA C |
1.0 |
0 |
5 |
20 |
-1.25 |
0.00 |
-25 |
UCLA A |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCI |
1.0 |
1 |
2 |
20 |
0.00 |
0.00 |
0 |
Stanford B12 |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
UCLA B |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Nein |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
| Total |
7.0 |
4 |
9 |
140 |
-0.04 |
0.00 |
-5 |
Miriam, Stanford Chicago
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA C |
1.0 |
1 |
2 |
20 |
0.00 |
0.00 |
0 |
UCLA A |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCI |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA D |
1.0 |
4 |
1 |
20 |
1.75 |
0.00 |
35 |
UCLA B |
1.0 |
1 |
2 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Riboflavin |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Nein |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
| Total |
9.0 |
14 |
7 |
180 |
0.58 |
0.00 |
105 |
Stacey, Stanford Chicago
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA C |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
UCLA A |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCI |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Stanford B12 |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCLA D |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
UCLA B |
1.0 |
6 |
0 |
20 |
3.00 |
0.00 |
60 |
Berkeley |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Riboflavin |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Nein |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
| Total |
9.0 |
24 |
4 |
180 |
1.22 |
0.00 |
220 |
Jeff, Stanford Chicago
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA C |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCLA A |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCI |
1.0 |
4 |
1 |
20 |
1.75 |
0.00 |
35 |
Stanford B12 |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
| Total |
4.0 |
8 |
2 |
80 |
0.88 |
0.00 |
70 |
Ellie, Stanford Chicago
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA D |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Riboflavin |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
| Total |
2.0 |
1 |
0 |
40 |
0.25 |
0.00 |
10 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford Chicago |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
UCLA A |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCI |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
Stanford B12 |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCLA D |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA B |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
Berkeley |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Riboflavin |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
Nein |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
| Total |
9.0 |
21 |
7 |
180 |
0.97 |
0.00 |
175 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford Chicago |
1.0 |
6 |
0 |
20 |
3.00 |
0.00 |
60 |
UCLA A |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCI |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Stanford B12 |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCLA D |
1.0 |
2 |
3 |
20 |
0.25 |
0.00 |
5 |
UCLA B |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Berkeley |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Riboflavin |
1.0 |
3 |
1 |
20 |
1.25 |
0.00 |
25 |
Nein |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
| Total |
9.0 |
25 |
5 |
180 |
1.25 |
0.00 |
225 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford Chicago |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCLA A |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCI |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford B12 |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCLA D |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA B |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Berkeley |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Riboflavin |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Nein |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
| Total |
9.0 |
11 |
5 |
180 |
0.47 |
0.00 |
85 |
Mia, UCLA C
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
Stanford Chicago |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCLA A |
1.0 |
0 |
2 |
20 |
-0.50 |
0.00 |
-10 |
UCI |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Stanford B12 |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA D |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCLA B |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Riboflavin |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Nein |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
| Total |
9.0 |
3 |
5 |
180 |
0.03 |
0.00 |
5 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA D |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Berkeley |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Riboflavin |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Nein |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Stanford Chicago |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCLA C |
1.0 |
4 |
0 |
20 |
2.00 |
0.00 |
40 |
UCLA A |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
UCI |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
9.0 |
16 |
1 |
180 |
0.86 |
0.00 |
155 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA D |
1.0 |
11 |
3 |
20 |
4.75 |
0.00 |
95 |
Berkeley |
1.0 |
5 |
0 |
20 |
2.50 |
0.00 |
50 |
Riboflavin |
1.0 |
7 |
2 |
20 |
3.00 |
0.00 |
60 |
Nein |
1.0 |
7 |
1 |
20 |
3.25 |
0.00 |
65 |
Stanford Chicago |
1.0 |
7 |
1 |
20 |
3.25 |
0.00 |
65 |
UCLA C |
1.0 |
6 |
2 |
20 |
2.50 |
0.00 |
50 |
UCLA A |
1.0 |
8 |
0 |
20 |
4.00 |
0.00 |
80 |
UCI |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Stanford B12 |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
| Total |
9.0 |
55 |
10 |
180 |
2.78 |
0.00 |
500 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA D |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Berkeley |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Riboflavin |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Nein |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Stanford Chicago |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCLA C |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCLA A |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
UCI |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
9.0 |
5 |
0 |
180 |
0.28 |
0.00 |
50 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA B |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Berkeley |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Riboflavin |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Nein |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Stanford Chicago |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCLA C |
1.0 |
5 |
0 |
20 |
2.50 |
0.00 |
50 |
UCLA A |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCI |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
9.0 |
15 |
1 |
180 |
0.81 |
0.00 |
145 |
KC, UCLA D
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA B |
1.0 |
4 |
1 |
20 |
1.75 |
0.00 |
35 |
Berkeley |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
Riboflavin |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
Nein |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Stanford Chicago |
1.0 |
3 |
2 |
20 |
1.00 |
0.00 |
20 |
UCLA C |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA A |
1.0 |
2 |
0 |
20 |
1.00 |
0.00 |
20 |
UCI |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
9.0 |
18 |
4 |
180 |
0.89 |
0.00 |
160 |
| Opponent |
GP |
10 |
-5 |
TUH |
P/TU |
P/N |
Pts |
UCLA B |
1.0 |
0 |
1 |
20 |
-0.25 |
0.00 |
-5 |
Berkeley |
1.0 |
3 |
0 |
20 |
1.50 |
0.00 |
30 |
Riboflavin |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
Nein |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Stanford Chicago |
1.0 |
2 |
1 |
20 |
0.75 |
0.00 |
15 |
UCLA C |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
UCLA A |
1.0 |
1 |
1 |
20 |
0.25 |
0.00 |
5 |
UCI |
1.0 |
0 |
0 |
20 |
0.00 |
0.00 |
0 |
Stanford B12 |
1.0 |
1 |
0 |
20 |
0.50 |
0.00 |
10 |
| Total |
9.0 |
9 |
3 |
180 |
0.42 |
0.00 |
75 |